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Résumé en
anglais
Given the spread of multidrug resistance and the number of antibiotics in
development, finding new antibacterial strategies becomes necessary. One of these
strategies is to use extracts of essential oils that are a potential reservoir of effective
antibacterial molecules. The objective of the study was to evaluate the possibility of
administering to animal, mixtures of carvacrol and eugenol (phenols),
cinnamaldehyde (aldehyde) and/or β-caryophyllene (alkene) encapsulated in lipid
nanocapsules to provide an optimal bio distribution and antimicrobial efficacy. These
suspensions were tested in vitro and the results showed an important antibacterial
activity against A. baumannii, a multidrugresistant microorganism responsible for
outbreaks in intensive care units, similar to the activity of non-encapsulated
mixtures. Subsequently, the suspensions activities were assessed with a murine
model of sepsis using the same A.Baumannii strain. These preliminary results
showed a mice survival varying from 45% to 55%. It is the first time that
antimicrobial essential oils can be administered intraperitonneally via nanomedicine.
These results are encouraging and further studies are needed to pursue the
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